Task: Answer the multiple-choice question.
Query: Which drug has a -21.083% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. O=C(CN1CCC(n2cnc3cc(F)ccc32)CC1)Nc1ccccc1Br
b. Nc1ccc(C(=O)OCC(=O)N2CCc3ccccc3C2)cc1[N+](=O)[O-]
Answer: b. Nc1ccc(C(=O)OCC(=O)N2CCc3ccccc3C2)cc1[N+](=O)[O-]
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Nc1ccc(C(=O)OCC(=O)N2CCc3ccccc3C2)cc1[N+](=O)[O-]
Nc1ccc(C(=O)OCC(=O)N2CCc3ccccc3C2)cc1[N+](=O)[O-]
[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl] 4-amino-3-nitrobenzoate